Sbir phase II, topic 331 development of a biosensor-based core needle tumor biopsy device
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201700050C
- Awardee
-
Actuated Medical, Inc. UEI VG84D4KN5LR5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,499,895
Award facts
- Opportunity
-
- BAAN44CO7900149 Solicitation number
- Contract value 100% obligated
- $1,499,895.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Bellefonte, PA 16823, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,499,895 |
About this award
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Actuated Medical, Inc. (AMI), doing business as Piezo Resonance Innovations Inc. The $1,499,895.00 Small Business Innovation Research (SBIR) Phase II contract is for the development of a biosensor-based core needle tumor biopsy device under Topic 331. AMI is a woman-owned small business manufacturer specializing in areas like tissue insertion, prototyping, and sensor technology. The company has received prior federal contract awards and grants from NIH and other agencies to support research and development of medical devices and therapies.
Quick answers
Who was awarded contract HHSN261201700050C?
HHSN261201700050C was awarded to Actuated Medical, Inc. by National Cancer Institute (National Institutes of Health) on September 19, 2017.
How much is contract HHSN261201700050C worth?
The government has obligated $1,499,895 on HHSN261201700050C.
Was contract HHSN261201700050C competed?
The extent of competition for HHSN261201700050C was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award